Timken (TKR) Tops Q2 EPS by 68c

Timken (NYSE: TKR) reported Q2 EPS of $1.02, $0.68 better than the analyst estimate of $0.34. Revenue for the quarter came in at $804 million versus the consensus estimate of $722.13 million.

Given the continued uncertainty surrounding COVID-19, the company is not providing full year 2020 sales and earnings guidance at this time.

For earnings history and earnings-related data on Timken (TKR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• DA Davidson Reiterates Neutral Rating on Timken (TKR)
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c